Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Lack of IFNγ signaling attenuates spread of influenza A virus in vivo and leads to reduced pathogenesis.

Nicol MQ, Campbell GM, Shaw DJ, Dransfield I, Ligertwood Y, Beard PM, Nash AA, Dutia BM.

Virology. 2019 Jan 2;526:155-164. doi: 10.1016/j.virol.2018.10.017. Epub 2018 Oct 31.

2.

Susceptibility of bone marrow-derived macrophages to influenza virus infection is dependent on macrophage phenotype.

Campbell GM, Nicol MQ, Dransfield I, Shaw DJ, Nash AA, Dutia BM.

J Gen Virol. 2015 Oct;96(10):2951-60. doi: 10.1099/jgv.0.000240. Epub 2015 Jul 9.

3.

Does vitamin D protect against respiratory viral infections?

Bryson KJ, Nash AA, Norval M.

Epidemiol Infect. 2014 Sep;142(9):1789-801. doi: 10.1017/S0950268814000193. Review.

PMID:
25030183
4.

Prevention of influenza by targeting host receptors using engineered proteins.

Connaris H, Govorkova EA, Ligertwood Y, Dutia BM, Yang L, Tauber S, Taylor MA, Alias N, Hagan R, Nash AA, Webster RG, Taylor GL.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6401-6. doi: 10.1073/pnas.1404205111. Epub 2014 Apr 14.

5.

A novel family of peptides with potent activity against influenza A viruses.

Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA.

J Gen Virol. 2012 May;93(Pt 5):980-6. doi: 10.1099/vir.0.038679-0. Epub 2012 Jan 18.

PMID:
22258859
6.

Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation.

Hoeve MA, Nash AA, Jackson D, Randall RE, Dransfield I.

PLoS One. 2012;7(1):e29443. doi: 10.1371/journal.pone.0029443. Epub 2012 Jan 4.

7.

Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37.

Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, Davidson DJ, Donis RO.

PLoS One. 2011;6(10):e25333. doi: 10.1371/journal.pone.0025333. Epub 2011 Oct 21.

8.

MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.

Aricò E, Monque DM, D'Agostino G, Moschella F, Venditti M, Kalinke U, Allen DJ, Stewart JP, Nash AA, Belardelli F, Ferrantini M.

Vaccine. 2011 May 23;29(23):3935-44. doi: 10.1016/j.vaccine.2011.03.092. Epub 2011 Apr 8. Erratum in: Vaccine. 2012 Apr 26;30(20):3145. Stewart, James P [added].

PMID:
21481326
9.

Antiviral RNA interference responses induced by Semliki Forest virus infection of mosquito cells: characterization, origin, and frequency-dependent functions of virus-derived small interfering RNAs.

Siu RW, Fragkoudis R, Simmonds P, Donald CL, Chase-Topping ME, Barry G, Attarzadeh-Yazdi G, Rodriguez-Andres J, Nash AA, Merits A, Fazakerley JK, Kohl A.

J Virol. 2011 Mar;85(6):2907-17. doi: 10.1128/JVI.02052-10. Epub 2010 Dec 29.

10.

A novel Cre recombinase imaging system for tracking lymphotropic virus infection in vivo.

Dutia BM, Reid SJ, Drummond DD, Ligertwood Y, Bennet I, Rietberg W, Silvia O, Jarvis MA, Nash AA.

PLoS One. 2009 Aug 4;4(8):e6492. doi: 10.1371/journal.pone.0006492.

11.

Advances in dissecting mosquito innate immune responses to arbovirus infection.

Fragkoudis R, Attarzadeh-Yazdi G, Nash AA, Fazakerley JK, Kohl A.

J Gen Virol. 2009 Sep;90(Pt 9):2061-72. doi: 10.1099/vir.0.013201-0. Epub 2009 Jul 1. Review.

PMID:
19570957
12.

Cortical development, plasticity and re-organization in children with cochlear implants.

Sharma A, Nash AA, Dorman M.

J Commun Disord. 2009 Jul-Aug;42(4):272-9. doi: 10.1016/j.jcomdis.2009.03.003. Epub 2009 Apr 5. Review.

13.

Cell-to-cell spread of the RNA interference response suppresses Semliki Forest virus (SFV) infection of mosquito cell cultures and cannot be antagonized by SFV.

Attarzadeh-Yazdi G, Fragkoudis R, Chi Y, Siu RW, Ulper L, Barry G, Rodriguez-Andres J, Nash AA, Bouloy M, Merits A, Fazakerley JK, Kohl A.

J Virol. 2009 Jun;83(11):5735-48. doi: 10.1128/JVI.02440-08. Epub 2009 Mar 18.

14.

Murid herpesvirus-4 induces chronic inflammation of intrahepatic bile ducts in mice deficient in gamma-interferon signalling.

Gangadharan B, Dutia BM, Rhind SM, Nash AA.

Hepatol Res. 2009 Feb;39(2):187-94. doi: 10.1111/j.1872-034X.2008.00440.x.

PMID:
19208039
15.

Selective uptake of small RNA molecules in the virion of murine gammaherpesvirus 68.

Cliffe AR, Nash AA, Dutia BM.

J Virol. 2009 Mar;83(5):2321-6. doi: 10.1128/JVI.02303-08. Epub 2008 Dec 24.

16.

Semliki Forest virus strongly reduces mosquito host defence signaling.

Fragkoudis R, Chi Y, Siu RW, Barry G, Attarzadeh-Yazdi G, Merits A, Nash AA, Fazakerley JK, Kohl A.

Insect Mol Biol. 2008 Dec;17(6):647-56. doi: 10.1111/j.1365-2583.2008.00834.x. Epub 2008 Sep 22.

17.

Murine gammaherpesvirus-induced fibrosis is associated with the development of alternatively activated macrophages.

Gangadharan B, Hoeve MA, Allen JE, Ebrahimi B, Rhind SM, Dutia BM, Nash AA.

J Leukoc Biol. 2008 Jul;84(1):50-8. doi: 10.1189/jlb.0507270. Epub 2008 Apr 24.

PMID:
18436582
18.

Expansion and activation of NK cell populations in a gammaherpesvirus infection.

Thomson RC, Petrik J, Nash AA, Dutia BM.

Scand J Immunol. 2008 May;67(5):489-95. doi: 10.1111/j.1365-3083.2008.02100.x. Epub 2008 Mar 18.

19.

The M4 gene of murine gammaherpesvirus 68 modulates latent infection.

Geere HM, Ligertwood Y, Templeton KM, Bennet I, Gangadharan B, Rhind SM, Nash AA, Dutia BM.

J Gen Virol. 2006 Apr;87(Pt 4):803-7.

PMID:
16528028
20.

Analysis of genomic homology of murine gammaherpesvirus (MHV)-72 to MHV-68 and impact of MHV-72 on the survival and tumorigenesis in the MHV-72-infected CB17 scid/scid and CB17+/+ mice.

Oda W, Mistrikova J, Stancekova M, Dutia BM, Nash AA, Takahata H, Jin Z, Oka T, Hayashi K.

Pathol Int. 2005 Sep;55(9):558-68.

PMID:
16143031
21.

Identification of a region of the virus genome involved in murine gammaherpesvirus 68-induced splenic pathology.

Dutia BM, Roy DJ, Ebrahimi B, Gangadharan B, Efstathiou S, Stewart JP, Nash AA.

J Gen Virol. 2004 Jun;85(Pt 6):1393-400.

PMID:
15166421
22.
23.
24.

Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis.

Macrae AI, Usherwood EJ, Husain SM, Flaño E, Kim IJ, Woodland DL, Nash AA, Blackman MA, Sample JT, Stewart JP.

J Virol. 2003 Sep;77(17):9700-9.

25.

The wood mouse is a natural host for Murid herpesvirus 4.

Blasdell K, McCracken C, Morris A, Nash AA, Begon M, Bennett M, Stewart JP.

J Gen Virol. 2003 Jan;84(Pt 1):111-3.

PMID:
12533706
26.

Transcriptome profile of murine gammaherpesvirus-68 lytic infection.

Ebrahimi B, Dutia BM, Roberts KL, Garcia-Ramirez JJ, Dickinson P, Stewart JP, Ghazal P, Roy DJ, Nash AA.

J Gen Virol. 2003 Jan;84(Pt 1):99-109.

PMID:
12533705
27.

Humoral immune response and protection from viral infection in mice vaccinated with inactivated MHV-68: effects of type I interferon.

Aricò E, Robertson K, Allen D, Ferrantini M, Belardelli F, Nash AA.

J Interferon Cytokine Res. 2002 Nov;22(11):1081-8.

PMID:
12513907
28.
29.

Analysis of a novel strain of murine gammaherpesvirus reveals a genomic locus important for acute pathogenesis.

Macrae AI, Dutia BM, Milligan S, Brownstein DG, Allen DJ, Mistrikova J, Davison AJ, Nash AA, Stewart JP.

J Virol. 2001 Jun;75(11):5315-27.

30.

Natural history of murine gamma-herpesvirus infection.

Nash AA, Dutia BM, Stewart JP, Davison AJ.

Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):569-79. Review.

31.

Characterization of the murine gammaherpesvirus 68 ORF74 product: a novel oncogenic G protein-coupled receptor.

Wakeling MN, Roy DJ, Nash AA, Stewart JP.

J Gen Virol. 2001 May;82(Pt 5):1187-97.

PMID:
11297694
32.
33.

Murine gammaherpesvirus M11 gene product inhibits apoptosis and is expressed during virus persistence.

Roy DJ, Ebrahimi BC, Dutia BM, Nash AA, Stewart JP.

Arch Virol. 2000;145(11):2411-20.

PMID:
11205127
34.

Murine gammaherpesvirus-68 infection of and persistence in the central nervous system.

Terry LA, Stewart JP, Nash AA, Fazakerley JK.

J Gen Virol. 2000 Nov;81(Pt 11):2635-43.

PMID:
11038374
35.

T cells and the regulation of herpes simplex virus latency and reactivation.

Nash AA.

J Exp Med. 2000 May 1;191(9):1455-8. No abstract available.

36.

Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.

Wu TT, Usherwood EJ, Stewart JP, Nash AA, Sun R.

J Virol. 2000 Apr;74(8):3659-67.

37.

Herpes virus latency in sensory ganglia--a comparison with endogenous neuronal gene expression.

Quinn JP, Dalziel RG, Nash AA.

Prog Neurobiol. 2000 Feb;60(2):167-79. Review.

PMID:
10639053
38.

2'-Deoxy-5-ethyl-beta-4'-thiouridine inhibits replication of murine gammaherpesvirus and delays the onset of virus latency.

Barnes A, Dyson H, Sunil-Chandra NP, Collins P, Nash AA.

Antivir Chem Chemother. 1999 Nov;10(6):321-6.

PMID:
10628807
39.

Kinetic and phenotypic changes in murine lymphocytes infected with murine gammaherpesvirus-68 in vitro.

Dutia BM, Stewart JP, Clayton RA, Dyson H, Nash AA.

J Gen Virol. 1999 Oct;80 ( Pt 10):2729-36.

PMID:
10573167
40.

The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40.

Carr JA, Rogerson JA, Mulqueen MJ, Roberts NA, Nash AA.

J Interferon Cytokine Res. 1999 Oct;19(10):1145-52.

PMID:
10547154
41.

Behavioural changes in the rat following infection with varicella-zoster virus.

Fleetwood-Walker SM, Quinn JP, Wallace C, Blackburn-Munro G, Kelly BG, Fiskerstrand CE, Nash AA, Dalziel RG.

J Gen Virol. 1999 Sep;80 ( Pt 9):2433-6.

PMID:
10501498
42.

Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection.

Dutia BM, Allen DJ, Dyson H, Nash AA.

Virology. 1999 Sep 1;261(2):173-9.

43.
44.

Substance use among adolescents with juvenile rheumatoid arthritis.

Nash AA, Britto MT, Lovell DJ, Passo MH, Rosenthal SL.

Arthritis Care Res. 1998 Oct;11(5):391-6.

PMID:
9830883
45.
46.

Immunological control of murine gammaherpesvirus infection is independent of perforin.

Usherwood EJ, Brooks JW, Sarawar SR, Cardin RD, Young WD, Allen DJ, Doherty PC, Nash AA.

J Gen Virol. 1997 Aug;78 ( Pt 8):2025-30.

PMID:
9267003
47.

Immune response to murine cell lines of glial origin transplanted into the central nervous system of adult mice.

Terry LA, Usherwood EJ, Lees S, MacIntyre N, Nash AA.

Immunology. 1997 Jul;91(3):436-43.

48.

Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68.

Mackett M, Stewart JP, de V Pepper S, Chee M, Efstathiou S, Nash AA, Arrand JR.

J Gen Virol. 1997 Jun;78 ( Pt 6):1425-33.

PMID:
9191940
50.

Characterisation of the immune response in a neural xenograft rejection paradigm.

Litchfield TM, Whiteley SJ, Yee KT, Tyers P, Usherwood EJ, Nash AA, Lund RD.

J Neuroimmunol. 1997 Mar;73(1-2):135-44.

PMID:
9058769

Supplemental Content

Support Center